The tweet was deleted by the author.
But we saved everything 🙂.
West Pharmaceutical Services will field Dana Hermon as a featured expert presenting on gap assessment, worst-case scenarios, and the platform approach for medical devices at the 2nd Annual Medical Device Biocompatibility and Risk Safety Summit.
The session aims to address evolving biocompatibility requirements and offer strategic insights for industry professionals. Hermon is expected to outline methodologies for managing medical device safety and compliance amid increasingly rigorous standards.
Hermon’s focus on robust compliance strategies comes amid broader industry shifts, as highlighted when West Pharmaceutical Services urged swift adaptation to emerging contamination control standards introduced by USP draft chapters in recent developments. The company’s commitment to advancing safety and innovation in medical devices is further underscored by its recent recognition for excellence in packaging and drug delivery innovation at international biopharma awards.